subject area of
- A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study Academic Article
- A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia Academic Article
- Clinical Predictors of Health-related Quality of Life Depend on Asthma Severity Academic Article
- Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions Academic Article
- ERK activity facilitates activation of the S-phase DNA damage checkpoint by modulating ATR function Academic Article
- ERK1 and ERK2 kinases activate hydroxyurea-induced S-phase checkpoint in MCF7 cells by mediating ATR activation Academic Article
- Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group Academic Article
- Expression of survivin and p16INK4a/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells Academic Article
- Fetal hemoglobin in sickle cell anemia: a glass half full? Academic Article
- Increase in Hemoglobin Concentration during Therapy with Hydroxyurea in Cooley's Anemia Academic Article
- Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation Academic Article
- Neutrophil Depletion Inhibits Airway Hyperresponsiveness Induced by Ozone Exposure Academic Article
- Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy Academic Article
- Quiescence-dependent activation of the p20K promoter in growth-arrested chicken embryo fibroblasts. Academic Article
- Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. Academic Article
- Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available Academic Article
- Sickle cell disease caused by Hb S/Québec-CHORI: Treatment with hydroxyurea and response Academic Article
- The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial Academic Article
- Treatment of thalassaemia major with phenylbutyrate and hydroxyurea Academic Article
- Update on the use of hydroxyurea therapy in sickle cell disease Academic Article